A new study reveals that many perceived benefits of gluten-free products, such as weight control and diabetes management, are ...

Key labs at the US CDC have shut down amid recent layoffs, raising concerns about tracking and controlling serious infections.

Hormone diets have taken off on social media as the latest weight loss trend, but their scientific validity remains ...

Pfizer has made the decision to discontinue the clinical development program for danuglipron, an oral GLP-1 receptor agonist, being investigated for chronic weight management.

In a US study, patients with severe eosinophilic esophagitis (EoE) by Index of Severity for EoE had poor responses to topical corticosteroid therapy.

The prevalence of irritable bowel syndrome and chronic idiopathic constipation rose significantly during the COVID-19 pandemic.

Threats include increasing demand, patients with increasingly complex needs, and falling payments for physicians. HealthDay News — The viability of hospital-based emergency care in the United States ...

A federal team responsible for setting poverty guidelines that determine who qualifies for health and food assistance has been fired.

The FDA has approved a tablet form of Livmarli (maralixibat) for cholestatic pruritus in patients with Alagille syndrome and progressive familial intrahepatic cholestasis.

Incidental BE was common and associated with high-risk features that were similar to or more severe than those found in BE diagnosed by traditional methods.

PBGENE-HBV is designed to potentially cure chronic hepatitis B by eliminating the root cause of the virus. The Food and Drug Administration (FDA) has granted Fast Track designation to PBGENE-HBV, an ...

Thanks for visiting Gastroenterology Advisor. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more. You’ve view ...